Barinthus Biotherapeutics plc (NASDAQ: BRNS)
$1.0250
+0.0775 ( +4.37% ) 35.9K
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
Market Data
Open
$1.0250
Previous close
$0.9475
Volume
35.9K
Market cap
$41.03M
Day range
$0.9350 - $1.0380
52 week range
$0.8008 - $4.1591
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | May 14, 2024 |
| 4 | Insider transactions | 1 | May 14, 2024 |
| 4 | Insider transactions | 1 | May 14, 2024 |
| 8-k/a | 8K-related | 47 | May 14, 2024 |
| 10-q | Quarterly Reports | 75 | May 13, 2024 |
| 8-k | 8K-related | 47 | May 13, 2024 |
| 8-k | 8K-related | 16 | Apr 18, 2024 |
| def | Proxies and info statements | 14 | Mar 22, 2024 |
| defa14a | Other | 3 | Mar 22, 2024 |
| ars | Annual reports | 1 | Mar 22, 2024 |